Galena Biopharma Inc. (GALE)

5.72
0.00 (0.00)
NASDAQ : Health Technology
Prev Close 5.72
Open 5.72
Day Low/High 5.56 / 5.85
52 Wk Low/High 3.43 / 19.80
Volume 55.42K
Avg Volume 886.60K
Exchange NASDAQ
Shares Outstanding 45.71M
Market Cap 11.98M
EPS -2,128.20
P/E Ratio N/A
Div & Yield N.A. (N.A)
Interesting GALE Put Options For December 20th

Interesting GALE Put Options For December 20th

Investors in Galena Biopharma Inc saw new options begin trading this week, for the December 20th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the GALE options chain for the new December 20th contracts and identified the following put contract of particular interest.

Galena Biopharma Announces Notice Of Allowance Of U.S. Patent Application For NeuVax(TM) (nelipepimut-S) Combination

Galena Biopharma Announces Notice Of Allowance Of U.S. Patent Application For NeuVax(TM) (nelipepimut-S) Combination

Patent Will Cover the Use of NeuVax in Combination With Herceptin(R) for Treating Patients Having Any HER2/neu Expressing Cancer

Galena Biopharma Doses First Patient In GALE-401 (Anagrelide Controlled Release) Phase 2 Clinical Trial

Galena Biopharma Doses First Patient In GALE-401 (Anagrelide Controlled Release) Phase 2 Clinical Trial

GALE-401 in Phase 2 Study in Patients With Elevated Platelet Counts in Myeloproliferative Neoplasms (MPNs) Including Essential Thrombocythemia (ET)

Why Galena Biopharma (GALE) Stock Is Spiking Today

Why Galena Biopharma (GALE) Stock Is Spiking Today

Galena Biopharma (GALE) shares are up double digits after analysts at MLV & Co reiterated their 'buy' rating on the stock.

Galena Biopharma (GALE) Flagged As Strong On High Volume

Galena Biopharma (GALE) Flagged As Strong On High Volume

Trade-Ideas LLC identified Galena Biopharma (GALE) as a strong on high relative volume candidate

Galena Fires CEO Ahn, Offers No Parting Gifts

Galena Fires CEO Ahn, Offers No Parting Gifts

CEOs who leave companies on good terms get cushy severance packages. Galena's Ahn did not.

Biotech Stock Mailbag: Threshold, Galena, CytRx

Biotech Stock Mailbag: Threshold, Galena, CytRx

Biotech columnist Adam Feuerstein answers readers' questions about health care.

Galena CEO Fired Following Stock-Promotions Scandal

Galena CEO Fired Following Stock-Promotions Scandal

Mark Ahn's forced exit from the troubled Galena follows an internal investigation by the board.

Biotech Stock Mailbag: Exact Sciences, Galena, Amgen

Biotech Stock Mailbag: Exact Sciences, Galena, Amgen

Biotech columnist Adam Feuerstein answers readers' questions about health care.

Galectin Pays Stock Promoters to Entice Retail Investors

Galectin Pays Stock Promoters to Entice Retail Investors

Like Galena BioPharma and The DreamTeam Group, Galectin is also paying for a promotional campaign designed to entice retail investors into buying its stock.

Galena Gives Sales Team Another Useless Product to Promote

Galena Gives Sales Team Another Useless Product to Promote

Galena stands little chance of delivering higher sales of Zuplenz than its previous marketer.

Trade-Ideas: Galena Biopharma (GALE) Is Today's "Perilous Reversal" Stock

Trade-Ideas: Galena Biopharma (GALE) Is Today's "Perilous Reversal" Stock

Trade-Ideas LLC identified Galena Biopharma (GALE) as a "perilous reversal" (up big yesterday but down big today) candidate

Galena Biopharma Receives Notice Of Allowance Of Broad U.S. Patent For NeuVax(TM) (nelipepimut-S)

Galena Biopharma Receives Notice Of Allowance Of Broad U.S. Patent For NeuVax(TM) (nelipepimut-S)

Allowed Claims Cover the Use of NeuVax Alone or in Combination to Prevent Recurrence of Any Her2/neu Expressing Tumor Having a FISH Rating of Less Than About 2.0

Stock To Watch: Galena Biopharma (GALE) In Perilous Reversal

Stock To Watch: Galena Biopharma (GALE) In Perilous Reversal

Trade-Ideas LLC identified Galena Biopharma (GALE) as a "perilous reversal" (up big yesterday but down big today) candidate

Galena Biopharma (GALE) Marked As A Dead Cat Bounce Stock

Galena Biopharma (GALE) Marked As A Dead Cat Bounce Stock

Trade-Ideas LLC identified Galena Biopharma (GALE) as a "dead cat bounce" (down big yesterday but up big today) candidate

Galena Promoting Experimental Breast Cancer Drug With Faux News Articles Again

Galena Promoting Experimental Breast Cancer Drug With Faux News Articles Again

Galena is paying a marketing firm to create promotions for its experimental breast cancer vaccine Neuvax. These Neuvax ads are dressed up to like legitimate news articles, except for the small disclaimer labeling them as "sponsored content paid for by a third party..."

Biotech Stock Hate Mailbag: The Hostile React-o-Meter Meltdown Edition

Biotech Stock Hate Mailbag: The Hostile React-o-Meter Meltdown Edition

I've been getting so much hate mail and nasty tweets lately, I thought it would be fun to throw them all into a single column for funny Friday read. There's probably something deeper to be said about market psychology and what an uptick in hate mail means for biotech investor sentiment, but I'll leave the interpretations up to you.

4 Stocks Under $10 to Keep an Eye On

4 Stocks Under $10 to Keep an Eye On

When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.